Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational Study
- PMID: 31103540
- DOI: 10.1016/j.jcin.2019.02.003
Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational Study
Abstract
Objectives: This study sought to report the incidence, characteristics, and clinical impact of device-related thrombus (DRT) following left atrial appendage occlusion (LAAO) with the AMPLATZER Amulet device (Abbott, Plymouth, Minnesota).
Background: DRT is a potential serious complication of LAAO, but the incidence and clinical impact of DRTs in a real-world setting are not well characterized.
Methods: A total of 1,088 patients were enrolled in a multicenter prospective study and followed for 1 year. All events were adjudicated by an independent committee, including the presence of DRT. Patients with DRT were reviewed for suboptimal device implantation and characterization of DRT formation. Multiple Cox regression was performed to identify predictors of DRT formation.
Results: Device implantation was successful in 1,078 (99%) patients, with 1-year follow-up completed in 96.3% of patients. A total of 18 DRTs occurred in 17 patients (1.7%/year), as a second DRT developed following complete resolution of an initial DRT in 1 patient. The left upper pulmonary vein ridge was not covered by the Amulet disc in 82% of DRT patients, indicating suboptimal implantation, with most thrombus developing in the untrabeculated area of the LAA ostium between the pulmonary vein ridge and the upper edge of the disc. Three (18%) DRT patients had an ischemic stroke, all within 3 months of DRT diagnosis. Patients with a DRT were at a greater risk for ischemic stroke or transient ischemic attack compared with non-DRT patients (hazard ratio: 5.27; 95% confidence interval: 1.58 to 17.55; p = 0.007). Larger LAA orifice width was a predictor of DRT formation (hazard ratio: 1.09; 95% confidence interval: 1.00 to 1.19; p = 0.04).
Conclusions: Following LAAO with the AMPLATZER Amulet device, DRT was observed infrequently. Although the presence of DRT was associated with an increased rate of ischemic stroke or transient ischemic attack as compared with patients without DRT, the large majority of DRT patients (82%) did not experience any ischemic neurologic events.
Keywords: LAA occlusion; atrial fibrillation; stroke; thrombus.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Device-Related Thrombus After Transcatheter Left Atrial Appendage Closure.JACC Cardiovasc Interv. 2019 Jun 10;12(11):1015-1017. doi: 10.1016/j.jcin.2019.03.039. Epub 2019 May 15. JACC Cardiovasc Interv. 2019. PMID: 31103539 No abstract available.
-
Do We Have Good Reasons to Pay Bleeding Penalty With Lifelong Aspirin After LAAO?JACC Cardiovasc Interv. 2019 Sep 9;12(17):1741. doi: 10.1016/j.jcin.2019.06.007. JACC Cardiovasc Interv. 2019. PMID: 31488302 No abstract available.
-
Reply: Do We Have Good Reasons to Pay Bleeding Penalty With Lifelong Aspirin After LAAO?JACC Cardiovasc Interv. 2019 Sep 9;12(17):1743. doi: 10.1016/j.jcin.2019.07.003. JACC Cardiovasc Interv. 2019. PMID: 31488304 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
